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Human epidermal neural crest stem cells as a source of
Schwann cells
Motoharu Sakaue* and Maya Sieber-Blum‡
ABSTRACT
We show that highly pure populations of humanSchwann cells can be
derived rapidly and in a straightforward way, without the need for
genetic manipulation, from human epidermal neural crest stem cells
[hEPI-NCSC(s)] present in the bulge of hair follicles. These human
Schwann cells promise to be a useful tool for cell-based therapies,
disease modelling and drug discovery. Schwann cells are glia that
support axons of peripheral nerves and are direct descendants of the
embryonic neural crest. Peripheral nerves are damaged in various
conditions, including through trauma or tumour-related surgery, and
Schwann cells are required for their repair and regeneration.
Schwann cells also promise to be useful for treating spinal cord
injuries. Ex vivo expansion of hEPI-NCSC isolated from hair bulge
explants, manipulating the WNT, sonic hedgehog and TGFβ
signalling pathways, and exposure of the cells to pertinent growth
factors led to the expression of the Schwann cell markers SOX10,
KROX20 (EGR2), p75NTR (NGFR), MBP and S100B by day 4 in
virtually all cells, and maturation was completed by 2 weeks of
differentiation. Gene expression profiling demonstrated expression of
transcripts for neurotrophic and angiogenic factors, as well as JUN, all
of which are essential for nerve regeneration. Co-culture of hEPI-
NCSC-derived human Schwann cells with rodent dorsal root ganglia
showed interaction of the Schwann cells with axons, providing
evidence of Schwann cell functionality. We conclude that hEPI-
NCSCs are a biologically relevant source for generating large and
highly pure populations of human Schwann cells.
KEY WORDS: hEPI-NCSC, Neural crest, Schwann cell, Peripheral
nerve, SOX10, KROX20, Protein zero, EPI-NCSCs
INTRODUCTION
Schwann cells are neural crest-derived glia that support axons of
peripheral nerves. Injuries to peripheral nerves are common; they
can be due to neuropathies, traumatic injury, tumour-related
surgery or repetitive compression (Pfister et al., 2011; Griffin
et al., 2014; Evans, 2001). Overall, peripheral nerve injury carries a
high cost to healthcare systems (Rosberg et al., 2005; Noble et al.,
1998). After peripheral nerve injury, the proximal stump of the
nerve is capable of regeneration and reinnervation. Surgical repair
for minor nerve reconstruction involves direct end-to-end
anastomosis (Griffin et al., 2014). In significant nerve injuries,
nerve repair requires bridging the gap and the introduction of
Schwann cells, together with Schwann cell-derived growth factors
and an extracellular matrix for guiding axonal extension and nerve
regeneration (Shirosaki et al., 2014). Axons regenerate along
aligned Schwann cells called bands of Büngner, which form a
permissive environment (Allodi et al., 2012). Scaffolds and tubes
are used as guidance materials for nerve grafts. Currently, autografts
from sensory nerves are typically used to repair large peripheral
nerve damage. Autografts have several disadvantages, however,
including damage to the donor nerve caused by the biopsy.
Schwann cells have also proven useful to treat spinal cord injuries
(e.g. Wiliams and Bunge, 2012; Bunge, 2008). The availability of
large numbers of human Schwann cells for autologous use and for
disease modelling and drug discovery is highly desirable.
Here, we provide a methodology for using hEPI-NCSC to generate
large and highly pure populations of human Schwann cells using a
straightforward strategy that avoids genetic modification and includes
manipulation of pertinent signalling pathways with small molecules.
hEPI-NCSC are multipotent adult stem cells that derive from the
neural crest, a transient tissue in vertebrate embryos that originates
from the dorsal aspect of the developing neural tube, the future spinal
cord. Neural crest cells become migratory and translocate away from
the forming neural tube to various locations within the embryo, where
they give rise to a wide array of cell types and tissues, including the
Schwann cells of the peripheral nervous system (Le Douarin and
Kalcheim, 1999).A subset ofmultipotent embryonic neural crest cells
invade the ectoderm early in development (Richardson and Sieber-
Blum, 1993; Narytnyk et al., 2014a), some of which become located
in a stem cell niche of the hair follicle, the ‘bulge’, where they persist
postnatallyand into adulthood (Sieber-Blumet al., 2004; Sieber-Blum
and Grim, 2004; Hu et al., 2006; Clewes et al., 2011; Sieber-Blum,
2014). Another type of neural crest-derived skin progenitor cell is a
Schwann cell precursor that arrives in the skin via projecting nerves
andgives rise tomelanocytes (Adameyko et al., 2009).CulturedhEPI-
NCSC proliferate rapidly, generating millions of stem cells within a
short period of time (Clewes et al., 2011), and they can undergo
directed differentiation into various cell types of clinical relevance,
including midbrain dopaminergic neurons (Narytnyk et al., 2014b),
osteocytes and melanocytes (Clewes et al., 2011). In mouse models
of spinal cord injury, murine EPI-NCSC have shown efficacy by
eliciting significant improvements in sensory connectivity and
touch perception (Sieber-Blum et al., 2006; Hu et al., 2010),
and canine EPI-NCSC (cEPI-NCSC) are promising candidates for
treating spinal cord injuries in dogs (Gericota et al., 2014; McMahill
et al., 2014; McMahill et al., 2015).
Various types of stem cell have been described as being able to
differentiate into Schwann-like cells and in assisting peripheral
nerve regeneration, primarily adipose tissue-derived stem cells
(Kingham et al., 2007; Reid et al., 2011; Tomita et al., 2013; Kolar
and Kingham, 2014; Razavi et al., 2013), as well as humanReceived 9 February 2015; Accepted 22 May 2015
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umbilical cord-derived mesenchymal stem cells (Lee et al., 2011),
skin mesenchymal precursors (Krause et al., 2014), embryonic stem
cell-derived neural crest cells (Ren et al., 2013), human amniotic
membrane (Banerjee et al., 2014), mesenchymal stem cells (Pan and
Cai, 2012), amniotic mesenchymal stem cells (Jiang et al., 2010)
and human embryonic stem cell-derived neurospheres (Ziegler
et al., 2011).
The primary significance of hEPI-NCSC is that they are
biologically the most relevant cell type to generate Schwann
cells, as they are direct descendants of the embryonic neural crest,
which is the source of Schwann cells in the body. We show here
that highly pure populations of human Schwann cells can be
generated from ex vivo expanded hEPI-NCSC rapidly and with high
efficiency. There is no need for purification because, by taking
advantage of the migratory ability of neural crest cells, highly
pure populations of hEPI-NCSC are generated in primary culture.
Notably, hEPI-NCSC can be isolated by a minimally invasive
procedure via a small biopsy of hairy skin and they can be
expanded ex vivo into millions of stem cells in adherent culture
(Clewes et al., 2011). Furthermore, hEPI-NCSC-derived Schwann
cells express neurotrophins and other factors essential for
nerve regeneration. Similar to mouse EPI-NCSC (mEPI-NCSC;
GEO accession number GSE4680;Hu et al., 2006; Sieber-Blum et al.,
2006) and cEPI-NCSC (McMahill et al., 2014; McMahill et al.,
2015), hEPI-NCSC and Schwann cells derived therefrom express the
VEGFA and VEGFB genes (GEO accession number GSE61273).
This is an important aspect, as angiogenesis is crucial for nerve repair
(Kolar and Kingham, 2014). Importantly, as we have shown in the
mouse spinal cord (Hu et al., 2010), in canine spinal cord (McMahill
et al., 2015), in athymic rats (M.S.-B., unpublished data) and in a
teratoma assay (McMahill et al., 2015), EPI-NCSC do not form
tumours in vivo, which is a hallmark of adult stem cells.
In vivo, Schwann cell precursors differentiate into immature
Schwann cells, which subsequently undergo terminal differentiation
into one of two types of mature Schwann cell: myelinating and non-
myelinating. Myelinating Schwann cells myelinate large diameter
neurons, whereas non-myelinating Schwann cells (Remak cells)
form mesaxons with unmyelinated small diameter neurons. Upon
nerve injury, Schwann cells alter their characteristics to acquire a
Schwann repair cell phenotype (Jessen and Mirsky, 2005; Arthur-
Farraj et al., 2012). Schwann cell differentiation andmaintenance are
dependent on growth factors that are provided by the embryonic
microenvironment and the axons that they interact with (Jessen and
Mirsky, 1999, 2005). The experimental design in this study is based
on these growth factor requirements.
RESULTS
Experimental design and master gene regulation
SOX10 function plays central roles in Schwann cell fate decision
and differentiation (Kelsh, 2006). hEPI-NCSC expressed SOX10,
as assessed by immunoreactivity, but predominantly in the
cytoplasm (data not shown). Pilot experiments suggested that
this SOX10 expression pattern was not conducive to efficient
Schwann cell differentiation. As SHH signalling and WNT
signalling regulate SOX10 expression (McNeill et al., 2012;
Werner et al., 2007), cells were treated transiently with SHH
and the GSK3β inhibitor CHIR99021, which led to SOX10
localisation in the nucleus and to highly efficient Schwann cell
differentiation (Fig. 1).
On day 0 of differentiation (D0), cells were treated for 24 h with
β-mercaptoethanol (βME), and all-trans retinoic acid (RA) was
added on D1 according to the method of Dezawa et al. (2001).
However, neither 3 nor 5 days of RA treatment was sufficient for
Schwann cell differentiation, as judged by cell morphology and
marker expression. RA was therefore left in the differentiation
medium throughout the culture period without any detectable
deleterious effects on the cells. At D0, SB431542, an inhibitor of
transforming growth factor beta 1 (TGFβ1) activin receptor-like
kinases (ALKs), was also added to the culture medium (Fig. 1). The
continued presence of SB431542 in the culture medium was
essential. On D3, FGF2, PDGF-BB, forskolin and neuregulin
1 (NRG1) were added.
Cell morphology during in vitro differentiation of hEPI-NCSC
Prior to differentiation, hEPI-NCSC had the typical stellate
morphology of neural crest stem cells (Fig. 2A), which remained
unchanged after pretreatment with SHH and CHIR99021 and
subculture (Fig. 2B). ByD4, cells becamemore elongated (Fig. 2C).
By D9, cells had assumed the slender, elongated morphology of
Schwann cells and started to form swirls in the culture plate
(Fig. 2D); they maintained this morphology for as long as they were
kept in culture (up to 30 days; Fig. 2E,F). Under these conditions,
cells continued to proliferate in differentiation culture until
approximately D9-D14. Schwann cells could be cryopreserved
and were viable after thawing and reculturing.
Timecourse of Schwann cell marker expression
Robust Schwann cell marker expression was observed by indirect
immunocytochemistry. All cells were immunopositive for the
neural crest stem cell and Schwann cell marker SOX10 (Table 1).
Nuclear SOX10 immunoreactivity was observed in increasing
numbers of cells with progressing differentiation, with a maximum
of 95.4±1.4% by D4, persisting until D14 (89.0±2.5%) and
subsequently declining (Fig. 3, Table 1; supplementary material
Fig. S1). KROX20 (EGR2) is a key marker for myelinating
Schwann cells and is regulated by SOX10 (Jessen and Mirsky,
2002; Reiprich et al., 2010) and RA (Heinen et al., 2013). All cells
expressed KROX20. Nuclear expression of KROX20 was
observed in increasing numbers of cells, with 91.9±0.8% on D9,
increasing to a maximum of 95.6±1.2% by D14 and, in contrast to
SOX10, without any significant decline thereafter (Fig. 3, Table 1;
supplementary material Fig. S1). All cells expressed p75NTR
(NGFR; a neural crest stem cell maker), myelin basic protein
(MBP) and S100B, as assessed by immunoreactivity, throughout
the culture period. The intensity of p75NTR immunofluorescence
visibly decreased with progressing cell differentiation (Fig. 3,
Table 1; supplementary material Figs S1 and S2). By contrast,
glial fibrillary acidic protein (GFAP) immunoreactivity was
not detected initially, and was at barely detectable levels only by
D30 (supplementary material Fig. S2; Table 1). Cells were,
however, intensely GFAP-immunoreactive in the absence of RA,
SHH and CHIR99021, with predominantly cytoplasmic SOX10
expression (supplementary material Fig. S3). Myelin P-zero (P0)
immunoreactivity was not detectable initially, became detectable
at D4, increased in intensity thereafter and remained strong
throughout the remainder of the culture period (Fig. 3, Table 1;
supplementary material Fig. S1). Marker expression was
confirmed at the RNA level by qPCR (Table 2).
Differential gene expression in hEPI-NCSC-derived Schwann
cells
Two comprehensive gene expression profiles were generated using
the Illumina platform and an HT12 v4 Array (GEO accession
number GSE61273), one with RNA from undifferentiated
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hEPI-NCSC and the other with RNA from hEPI-NCSC-derived
Schwann cells. The Diff Score is a transformation of the P-value that
provides directionality to the P-value based on the difference
between the average signal in the reference group versus the
comparison group. Of a total of 47,229 transcripts, 3690 genes were
differentially expressed with P≤0.01; of these, 2954 genes were
differentially expressed with P≤0.001.
As expected, highly differentially expressed genes concerned
primarily metabolic processes, general differentiation markers,
transporters of molecules, and regulation of cell behaviour.
Thirty-one significantly downregulated transcripts in Schwann
cells (P≤0.01) concerned cell migration, and an estimated >200
downregulated genes (P<0.01) regulate cell proliferation.
Extracellular proteases produced by migrating neural crest cells
serve to degrade embryonic extracellular matrix. Four
metalloproteases of the MMP family [MMP2, MMP3, IMP2
(IMMP2L) and BSG; P<0.0001] and nine members of the ADAM
family of proteinases (ADAM12, 15, 17; and ADAMTS2, 5, 6;
ADAMTSL1, 4; P<0.001) were significantly downregulated.
Transcripts of KROX20, a gene specific for the myelinating type of
Schwann cell, were upregulated 1.45-fold (P<0.001) in Schwann
cells. Several myelin proteins were upregulated. MBP transcripts, for
instance, were upregulated 3.2-fold (P<0.001). Cholesterol is a major
component of myelin. Twenty-one genes involved in cholesterol
metabolism were upregulated with high significance. For example,
transcripts encoding MALL, a member of the MAL family of
proteolipids that localises to cholesterol-enriched membranes, were
upregulated 3.4-fold (P<0.001). Emopamil-binding protein (EBP),
which was upregulated 1.7-fold (P<0.001), encodes a sterol isomerase
involved in synthesizing 3β-hydroxysteroid-Δ8,Δ7-isomerase, which
in turn is responsible for one of the final steps in the production of
cholesterol. Transcripts encodingOSBPL5, amemberof theoxysterol-
binding protein (OSBP) family, which is a group of intracellular lipid
receptors that play a key role in maintaining cholesterol balance in the
body,wereupregulated1.14-fold (P<0.001). Transcripts of superoxide
dismutase 1 (SOD1), mutations in which are implicated in multiple
sclerosis, a de-myelinating disease, were upregulated 1.7-fold
(P<0.001) in Schwann cells. Transcripts of caveolin 1 (CAV1),
mutations in which are associated with Berardinelli–Seip congenital
lipodystrophy, were upregulated 2.2-fold (P<0.001) (Table 3).
In vivo, Schwann cells produce neurotrophins and other factors
that support neuronal survival, including nerve growth factor (NGF)
(Rush, 1984), neurotrophin 4/5 (NT-4/5; NTF4) (Funakoshi et al.,
1993), brain-derived neurotrophic factor (BDNF) (Meyer et al.,
1992), fibroblast growth factor 2 (FGF2) (Ornitz and Itoh, 2001),
FGF5 (McGeachie et al., 2001), leukaemia inhibitory factor (LIF)
(Kurek et al., 1996) and interleukin 6 (IL6) (Bolin et al., 1995).
Neurotrophin 3 (NT3; NTF3), FGF2, BDNF and LIF were
expressed in both hEPI-NCSC and Schwann cells derived
therefrom with highest probability (detection P=0). FGF5 (2.2-
fold), BDNF (2.4-fold), FGF2 (5.6-fold) and IL6 (11.6-fold) were
significantly upregulated in Schwann cells (Table 3). Angiogenesis
is an important aspect of successful nerve regeneration. Both
VEGFA and VEGFB were expressed in hEPI-NCSC and in
Schwann cells derived therefrom with highest probability
(detection P=0); VEGFA was upregulated sixfold (Table 3). JUN
(c-Jun) expression in Schwann cells is essential and sufficient for
supporting nerve repair, as it regulates the de-differentiation of
myelinating Schwann cells into the regenerative type of Schwann
cell (Arthur-Farraj et al., 2012). JUN transcripts were detected in
both hEPI-NCSC and hEPI-NCSC-derived Schwann cells with
Fig. 2. Cell morphology before and during differentiation. (A) D−3,
showing stellate morphology typical for neural crest cells. (B) D0, showing
unchanged cell morphology after SHH andCHIR99021 treatment. (C) D4, cells
continued to proliferate and started to change morphology. (D-F) D9 and later,
cells became elongated and morphology was maintained in prolonged culture.
F′ shows cells at higher magnification. Scale bars: 50 µm.
Fig. 1. Experimental design. Cells were pretreated with rhSHH
and CHIR99021 for 24 h in expansion (XP) medium [differentiation
day (D) −3 to D−1]. Cells were then subcultured on D−1 (arrow) into
XP medium and allowed to recover for 24 h. On D0, SB431542 was
first added and cells were treated with β-mercaptoethanol (βME) for
24 h. On D1, retinoic acid (RA) was first added. On D3,
differentiation factors FGF2, PDGF-BB, NRG1 and forskolin were
first added. All components were added fresh every 48 h.
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highest probability (detection P=0). See also the heat map in
supplementary material Fig. S4.
Functionality of hEPI-NCSC-derived human Schwann cells
in vitro
Next we addressed the functionality of Schwann cells in vitro by
determining whether hEPI-NCSC-derived Schwann cells can interact
with neurites. We co-cultured hEPI-NCSC-derived Schwann cells
with camptothecin-treated rodent dorsal root ganglia (DRG) explants
(supplementary material Fig. S5). In contrast to cytosine arabinoside,
in our hands (data not shown), camptothecin efficiently removed
endogenous Schwann cells but was toxic selectively to large diameter
sensory neurons (supplementary material Fig. S5A′), as has been
documented previously (Bhanu and Kondapi, 2010). Confocal
microscopy showed bead-like myelin P0 immunoreactivity above
the human Schwann cells, which corresponded precisely with murine
DRG neuronal processes (Fig. 4Aa,a′). Anti-human nuclear antibody
immunofluorescence confirmed that all P0-immunoreactive Schwann
cellswere of human origin (Fig. 4Aa-b, pale blue fluorescence). There
was a close interaction of Schwann cell-derived P0 immunoreactivity
with neurite-derived EGFP fluorescence (Fig. 4Ac).
As E15.5 rat embryos do not yet have differentiated Schwann
cells (Jessen et al., 1994), we repeated the co-culture experiments
with whole DRG explants from E15.5 rat embryos. Whereas
numerous emigrating non-neuronal cells were present in the
absence of camptothecin (supplementary material Fig. S5B),
camptothecin-treated DRG explants were clear of non-neuronal
cells (supplementary material Fig. S5B′). hEPI-NCSC-derived
Schwann cells aligned with the neurites radiating from the explant
(Fig. 4B; supplementary material Fig. S5B″). The cell bodies and
processes of Schwann cells were P0 immunoreactive (Fig. 4B).
Again, bead-like Schwann cell P0 immunoreactivity was
consistently and precisely in close association with neurites
(Fig. 4B). All cells were immunopositive with the anti-human
Table 1. Marker expression as assessed by immunocytochemistry
Culture
Epitope expression (%)
Day SOX10 KROX20 P75NTR S100B GFAP MBP P0
0 100 (52.5±8.1) 100 (38.3±10.1) 100 100 0 100 100
4 100 (95.4±1.4)* 100 (74.7±5.6)* 100 100 0 100 100
9 100 (96.1±0.8)* 100 (91.9±0.8)* 100 100 0 100 100
14 100 (89.0±2.5)* 100 (95.6±1.2)* 100 100 0 100 100
19 100 (45.8±3.7) 100 (90.4±2.1)* 100 100 100‡ 100 100
30 100 (23.6±2.4)* 100 (90.2±2.1)* 100 100 100‡ 100 100
Values in parentheses indicate the percentage of cells (±s.e.m.) that also had nuclear marker expression, in addition to cytoplasmic localisation.
*Statistically significant difference to D0 value (P<0.05, Dunnett’s test).
‡Intensity of fluorescence at low levels. n=6-10.
Fig. 3. Immunocytochemistry. (A-B″) D0. (A-A″) All cells exhibit SOX10 (A) and p75NTR (A′) immunofluorescence. (B-B″) KROX20 is expressed in all cells (B),
whereas P0 is undetectable (B′). (C-D″) D4. (C-C″) All cells exhibit SOX10 (C) and p75NTR (C′) immunofluorescence. (D-D″) All cells exhibit KROX20
immunoreactivity (D), while P0 immunoreactivity is detected in all cells at low levels (D′). (E-F″) D9. (E-E″) All cells are SOX10 positive, showing intense SOX10
nuclear immunoreactivity (E), but decreased p75NTR immunoreactivity (E′). (F-F″) All cells show strong KROX20 immunoreactivity, mostly nuclear (F), and weak
P0 immunoreactivity (F′); inset shows P0 immunoreactivity at higher magnification. (G-H″) D14. (G-G″) Cells show strong nuclear SOX10 immunoreactivity
(G) and weak p75NTR immunoreactivity (G′). (H-H″) KROX20 immunoreactivity, showing mostly nuclear localisation (H), and weak P0 immunoreactivity in all
cells (H′); inset shows P0 immunoreactivity at higher magnification. DAPI is blue in merged images (A″-H″). Scale bars: 50 µm.
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nuclear antibody (Fig. 4Bc), confirming the human origin of the
Schwann cells. Anti-Hu/DAPI double staining showed that the co-
cultures did not contain any non-human non-neural cells, as all
DAPI-stained nuclei were also anti-Hu immunoreactive (Fig. 4Bd).
Since experiments in two different co-culture systems showed
close association of hEPI-NCSC-derived Schwann cells with
neurites, we next investigated this interaction at the ultrastructural
level in co-cultures of Schwann cells and rat embryo DRG. Fig. 5
shows electron microscopy images of hEPI-NCSC–DRG co-
cultures. Fig. 5A shows a Schwann cell attached to the well
bottom. Bundles of DRG-derived neurites were engulfed by
protrusions from Schwann cells (Fig. 5B,B′, arrows and bracket).
Fig. 5C,C′ show three neurites forming close membrane-to-
membrane contacts with the cell on the right (marked by the five
asterisks), which is considered a prerequisite for subsequent
myelination. Thus, close interactions of hEPI-NCSC-derived
Schwann cells with rat embryo DRG axons were also observed at
the ultrastructural level.
DISCUSSION
A readily available source of large numbers of highly pure human
Schwann cells is desirable for use in surgery to repair damage to
peripheral nerves, potentially for other cell-based therapies, and for
research purposes. Here, we show that hEPI-NCSC are a
biologically relevant source of adult stem cells for generating
large and highly pure populations of human Schwann cells. hEPI-
NCSC-derived Schwann cells exhibited characteristic morphology,
expressed relevant markers at the protein and RNA levels, and
interacted with axons of rodent DRGs in explant culture, providing
evidence of the functionality of Schwann cells.
A central aspect of our methodology concerns the augmentation
of SHH and canonical WNT signalling, which resulted in increased
nuclear localisation of SOX10. The transcription factor SOX10 is a
key regulator in neural crest formation and in Schwann cell fate
decision and differentiation. SOX10 is also involved in regulating
expression of the myelin proteins P0 and MBP. By contrast, SOX10
function must be shut off for neuronal differentiation to proceed
(Rehberg et al., 2002). Although hEPI-NCSC are direct descendants
of the embryonic neural crest, gene expression profiles of hEPI-
NCSC and embryonic neural crest stem cells are not identical (Hu
et al., 2006). Whereas SOX10 has a nuclear localisation in the
embryonic neural crest, hEPI-NCSC showed predominantly
cytoplasmic SOX10 immunoreactivity. WNT and SHH signalling
are part of the network that regulates SOX10 expression (Werner
et al., 2007; McNeill et al., 2012), which explains the increased
nuclear SOX10 localisation in hEPI-NCSC after SHH and
CHIR99021 treatment. SOX10 is a shuttle protein. Continuous
entry and exit to and from the nucleus is essential for its function.
This involves post-translational modification of SOX10 in the
cytoplasm, which is lost over time while SOX10 resides in the
nucleus (Rehberg et al., 2002). Nuclear entry/exit of SOX10 is
thought to represent a fast-acting regulatory system for SOX10
function (Rehberg et al., 2002). SOX10 expression is nuclear in vivo
in mature nerves and in distal stumps after nerve transection. The
predominantly cytoplasmic localisation of SOX10 immunoreactivity
at the end of the 30-day differentiation period might reflect a loss of
the SHH and CHIR99021 effects.
SOX10 regulates the KROX20 gene (Reiprich et al., 2010).
Persistent KROX20 expression is characteristic of myelinating
Schwann cells (Allodi et al., 2012), as is MBP and P0 expression. In
the present study, Schwann cells exhibited strong nuclear KROX20
immunoreactivity throughout the culture period. Surprisingly, there
was strong MBP expression already at D0. This can be explained by
the fact that SOX10 and KROX20, both of which are expressed at
that time, synergistically regulate MBP expression (Marathe et al.,
2013). The intensity of MBP immunofluorescence declined
somewhat with time in culture. However, in co-culture with DRG
neurons we observed intense MBP immunofluorescence (data not
shown), illustrating reciprocal influences between neurites and
Schwann cells. p75NTR immunofluorescence was intense at the
onset of differentiation of hEPI-NCSC into Schwann cells, due to
the fact that p75NTR is expressed by neural crest stem cells. The
intensity of p75NTR immunofluorescence decreased with
progressing differentiation in culture, which is characteristic for
myelinating Schwann cells. GFAP immunoreactivity was not
detected initially but was present at modest levels by D30.
However, in the absence of RA, SHH and CHIR99021, all cells
were robustly GFAP immunoreactive in addition to showing
cytoplasmic SOX10 localisation. These data suggested that the
precise type, and possibly duration, of SOX10 function contributes
to the identity of the Schwann cell subtype.
Gene expression profiling confirmed that with progressing
in vitro differentiation Schwann cells reduced the expression of
transcripts characteristic for neural crest stem cells, including genes
involved in cell migration, cell proliferation and cell invasiveness.
There was a concomitant increase in the expression of MBP,
genes involved in cholesterol metabolism, which is relevant to
myelin synthesis, and in the expression of transcripts of relevant
neurotrophins and other pertinent growth factors. Importantly, gene
expression profiling showed the expression of JUN transcripts, a
transcription factor in Schwann cells that is essential for nerve repair
as it regulates the molecular reprogramming involved in turning
mature Schwann cells into the regenerative Schwann cell type after
nerve injury (Arthur-Farraj et al., 2012). Overall, our gene
expression data suggest that neural crest stem cell-characteristic
Table 2. qPCR analysis of Schwann cell marker gene expression after
differentiation
Gene
Day of
differentiation
Relative
expression (%)
Average expression
(%) ±s.e.
SOX10 −3 1 100.0±3.3
21 5.05±0.05 505.5±5.0*
P75NTR −3 1 100.0±3.9
21 2.91±0.06 291.5±5.7*
GFAP −3 1 100.0±9.7
21 2.03±0.04 203.0±4.4*
Expression was compared before (D–3, set to 1) and after (D21) differentiation.
*Statistically significant difference (P<0.05; n=3).
Table 3. Fold increase (P<0.001) in expression in Schwann cells in the
Illumina gene expression profile
Gene Fold increase
BDNF 2.4
CAV1 2.2
EBP 1.7
FGF2 5.6
FGF5 2.2
IL6 11.6
KROX20 1.45
MALL 3.4
MBP 3.2
OSBPL5 1.14
SOD1 1.7
VEGFA 6.0
Fold increase in Schwann cells compared with hEPI-NCSC.
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genes are downregulated and Schwann cell/myelin-related
transcripts are upregulated with progressing differentiation.
The notion that hEPI-NCSC-derived Schwann cells are
functionally active is supported by our observation of close
alignment and interactions of the Schwann cells with neurites in co-
culture, as shownbyconfocal and electronmicroscopy. Schwann cells
exhibited multiple protrusions that grew towards bundles of neurites
and, in some cases, very close membrane-membrane associations
were formed between the Schwann cells and neurites. The latter is
considered an initial stage of myelination. There are no convincing
reports in the literature on the generation of myelinating human
Schwann cells in human Schwann cell-rodent DRG co-cultures.
Schwann cell differentiation was successful only in the
continuous presence of SB431542, which is a selective and potent
inhibitor of ALK4, 5 and 7 (ACVR1B, TGFBR1 and ACVR1C).
SB431542 inhibits endogenous activin and TGFβ signalling
without affecting more divergent BMP signalling that utilises
ALK1, 2, 3 and 6 (ACVRL1, ACVR1, BMPR1A and BMPR1B)
(Laping et al., 2002). Most likely, inclusion of SB431542 was
necessary to guide stem cells away from the neuronal cell lineage, to
inhibit TGFβ-related apoptosis early in Schwann cell differentiation
and to avoid inhibition of SOX10 and P0 expression by TGFβ
signalling (Morgan et al., 1994; Jessen and Mirsky, 2005; Kelsh,
2006). The βME/RA protocol for Schwann cell differentiation
developed by Dezawa et al. (2001) for rat marrow stromal cells has
also successfully been used with rat adipose-derived stem cells
(Kingham et al., 2007), but was not applicable to hEPI-NCSC. RA
treatment for 3 or 5 days (data not shown) was not conducive to
Schwann cell differentiation. However, when RA was present
throughout the culture period Schwann cell differentiation
proceeded efficiently. The reason for this discrepancy between
rodent and human cells is not obvious, as RA affects many
signalling pathways that regulate cell differentiation. Alternatively,
prolonged RA treatment might be required because depletion of the
hEPI-NCSC pool occurs over a prolonged period of time in culture
only due to continued self-renewal.
Notably, hEPI-NCSC-derived Schwann cells expressed transcripts
for neurotrophic factors that are essential for nerve regeneration, and
are expressed by Schwann cells in vivo during nerve regeneration,
includingNGF (Rush, 1984), NT-4/5 (Funakoshi et al., 1993), BDNF
(Meyeret al., 1992), FGF2 (Ornitz and Itoh, 2001), FGF5 (McGeachie
et al., 2001), LIF (Kurek et al., 1996) and IL6 (Bolin et al., 1995).
Another important aspect for successful nerve regeneration includes
cues from Schwann cells that promote angiogenesis in the injured
Fig. 4. Interaction of hEPI-NCSC-derived Schwann cells with neurites from rodent DRG as observed by confocal microscopy. (A) Cultures fixed at
11 days of co-culture with dissociated DRG neurons from adult ‘Green’ mouse (EGFP fluorescence). (a) P0 immunoreactivity (red) and anti-human nuclear
antibody (pale blue) merged images. Four human Schwann cells are visible; bead-like P0 immunofluorescence is apparent above the Schwann cells. (a′) Merge
of area in panel awith EGFP fluorescence. The bead-like P0-positive structures (red) correspond precisely with neuronal processes (green). (b) The boxed area in
a′ at higher magnification. Slice thickness is 0.72 µm. (c) Orthogonal reconstruction of the area indicated by the arrow in b, showing close interaction between
Schwann cell process and neurite. (B) Cultures were fixed at day 21 of co-culture with whole DRG explants from E15.5 rat embryos. (a) P0 (red) fluorescence.
Schwann cell bodies are in aligned orientation; bead-like structures are apparent in processes and on cell bodies. (b) Neurofilament fluorescence (green) in same
area as in panel a. The orientation of neurites corresponds to that of Schwann cells in panel a. (c) P0 and anti-human nuclear antibody (anti-Hu, pale blue) merged
images; all Schwann cells are of human origin. (d) Merge of P0, anti-human nuclear antibody, neurofilament and DAPI nuclear stain (dark blue) showing absence
of any non-human cells. (a′-d′) Higher magnification of boxed areas in a-d; arrow indicates P0 and neurofilament double-positive structures. Scale bars: 50 µm.
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microenvironment. VEGFA is a key angiogenic factor expressed in
hEPI-NCSC, and VEGFA transcripts were upregulated sixfold in
hEPI-NCSC-derived Schwann cells. It is thus likely that hEPI-NCSC-
derived Schwann cells will contribute to angiogenesis in vivo. This
notion is strongly supported by our observations that mouse EPI-
NCSC (mEPI-NCSC; Hu et al., 2010) and cEPI-NCSC (McMahill
et al., 2015) promote angiogenesis in the spinal cord injuryofmice and
dogs.
hEPI-NCSC are isolated directly from bulge explants as highly
pure populations of migrating multipotent neural crest-derived stem
cells without the need for purification or further manipulation, and
within a short period of time. Krause et al. (2014) reported that skin-
derived precursor cells (SKPs) from rodents and from human
foreskin could generate myelinating Schwann cells. The method
used by Krause et al. (2014) differs from ours in that it involves time-
consuming isolation and purification procedures, as pieces of dermis
had to be enzymatically digested, manually dissociated by pipetting,
strained, and cultured to generate primary spheres. Primary spheres
were subsequently treated with collagenase, followed by additional
treatments, and finally placed into culture to generate secondary
spheres, which were subsequently used for cell differentiation.
What is the Schwann cell subtype of the hEPI-NCSC-derived
human Schwann cells? According to marker expression (high
KROX20, low P0 expression in the absence of neurites) the hEPI-
NCSC-derived Schwann cells could be categorised either as
myelinating immature Schwann cells or as Remak cells (non-
myelinating Schwann cells). However, KROX20 is specific for
myelinating Schwann cells (Allodi et al., 2012) and was expressed
throughout the 30-day culture period. P0 immunoreactivity
increased over time in culture and was intense in co-culture with
neurons. In the protocol presented here, immunoreactivity for
GFAP, which is a marker for non-myelinating and immature
Schwann cells (Allodi et al., 2012), was not detected initially and at
low levels only towards the end of the 30-day culture period.
Expression of p75NTR was strong initially but decreased with
advancing in vitro differentiation. In addition to being a neural crest
stem cell marker, p75NTR expression can also be indicative of
non-myelinating Schwann cells or immature myelinating Schwann
cells (Allodi et al., 2012). Taken together, at the end of the 30-day
culture period, hEPI-NCSC-derived Schwann cells expressed
markers for myelinating Schwann cells (KROX20, MBP, P0,
S100B) as well as markers characteristic for immature Schwann
cells and non-myelinating Schwann cells, that is (low) p75NTR
immunofluorescence and (low) GFAP immunofluorescence, as
well as JUN transcripts. Overall, the best fit for a Schwann cell
subtype in the current culture conditions is an immature myelinating
Fig. 5. Close interaction of hEPI-NCSC-derived Schwann cells with neurites from rodent DRG as observed by electron microscopy. (A) A Schwann
cell (nu, nucleus) attached to thewell bottom (wb). In the cytoplasm, mitochondria (dark, rounded) and endoplasmic reticulum (elongated double-track structures)
are visible. (B) Bundle of neurites in transverse section (boxed area) enclosed by processes from two cells: from the left (cell with visible nucleus) and a process
from a cell to the right of the image. (B′) Higher magnification of boxed area in B. The cytoplasm (cp) of the cell to the left showsmitochondria (m) and endoplasmic
reticulum (rER). Individual neurites (neu) within the cluster are visible in transverse section. Processes in proximity to the cluster of neurites aremarked by arrows;
the process originating from the cell to the right is indicated by a bracket. (C) Cluster of neurites in transverse section (microtubules detectable), showing
three neurites in close membrane proximity with a cell to the right (the cytoplasm of which is visible). (C′) Higher magnification of boxed area in C. Three neurites
have made close contact with the cell to the right (five asterisks). Note that the ultrastructure is compromised due to a long lag time between fixation and
processing for electron microscopy, as well as shipping in buffer rather than in fixative. Scale bars: 5 µm in A,B; 500 nm in B′,C,C′.
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type Schwann cell. Culturing of the cells under standard
myelinating and non-myelination culture conditions would further
clarify this issue.
Taken together, hEPI-NCSC are multipotent human adult stem
cells that are readily accessible in the bulge of hair follicles. Owing
to their migratory ability, hEPI-NCSC can be isolated as a highly
pure population of multipotent stem cells, and they can be expanded
rapidly ex vivo. In this study, we demonstrated that hEPI-NCSC can
be differentiated into human Schwann cells rapidly, with high
efficiency and without the need for genetic manipulation or
purification. hEPI-NCSC-derived Schwann cells express markers
of myelinating Schwann cells that are conducive to nerve repair. For
these reasons combined, hEPI-NCSC-derived human Schwann
cells promise to be a valuable resource for translational research.
MATERIALS AND METHODS
hEPI-NCSC cultures
De-identified hairy skin biopsies were obtained with ethical approval
(REC REF: 08/H0907/1) and hEPI-NCSC were isolated from human hair
follicles exactly as described previously (Clewes et al., 2011). Briefly,
anagen hair follicles were dissected and the bulge section placed into
adherent culture. hEPI-NCSC emigrating from bulge explants were
subcultured, expanded for 6 days exactly as described (Clewes et al.,
2011) and cryopreserved.
Differentiation of hEPI-NCSC into Schwann cells
Cryopreserved hEPI-NCSC were thawed, seeded at 2500-5000 cells per
CELLstart-coated 35-mm culture plate and cultured at 36.8°C, 5% CO2
and 5% O2 for several days. At differentiation day minus 3 (D−3), cells in
XP medium were treated with 500 ng/ml recombinant human (rh) sonic
hedgehog (C24II) N-terminus (rhSHH) and 500 nM CHIR99021 for 2
days. At D–1, the cells were subcultured into XP medium at a density of
30,000 cells per 35-mm plate and 1000 cells per poly-D-lysine- and
laminin-coated 13-mm diameter glass coverslip. The next day (D0), cells
were cultured in Alpha-modified MEM in the presence of 10% FBS and
1 mM βME for 24 h, which was followed by treatment with 35 ng/ml all-
trans RA according to the method of Dezawa et al. (2001). At D3, the FBS
concentration was reduced to 1%. Starting at D0, 10 µM SB431542 was
also added to the culture medium. RA and SB431542 remained in the
culture medium throughout the culture period. At D3, 10 ng/ml rhFGF2,
5 ng/ml rhPDGF-BB, 5 µM forskolin and 200 ng/ml rhNRG1 were added
to the culture medium. The culture medium was exchanged every 48 h. For
details of equipment and reagents see supplementary material Table S1.
DRG explant culture
‘Green’ mice [C57BL/6-TgN(ACTbEGFP)1Osb; Okabe et al., 1997] and
wild-type Wistar rats were handled in accordance with protocols approved
by the Animal Care Committee of Newcastle University (project licence
60/3876). Whole-mount DRG explants were dissected from E15.5 Wistar
rat embryos (Päiväläinen et al., 2008; Liu et al., 2011). Dissociated DRG
cultures were prepared from adult Green mice (Malin et al., 2007; Johnson
et al., 2001). To remove non-neuronal cells, DRG explants were treated with
camptothecin (20 µM) three times for 48 h each, on D2-D5, D6-D8 and
D13-D15.
Co-cultures of hEPI-NCSC-derived Schwann cells and DRG
neurons
At D28, hEPI-NCSC-derived Schwann cells were detached with TrypLE
and seeded onto camptothecin-treated DRG explants on D17 of DRG
explant culture or D10 of dissociated DRG neuron culture, at 12,000
Schwann cells per 13-mm coverslip, and incubated for 21 days in co-culture
medium consisting of alpha-modified MEM, penicillin/streptomycin, B27
supplement without RA, 5 ng/ml rhPDGF-BB, 5 µM forskolin, 10 ng/ml
rhNRG1, 50 µg/ml ascorbic acid, 20 ng/ml rhPDGF, 20 ng/ml GDNF,
20 ng/ml rhβNGF, 20 ng/ml rhNT3 and 10 µM SB431542. For details of
reagents see supplementary material Table S1.
Indirect immunocytochemistry
Indirect immunocytochemistry was performed exactly as described
previously (Clewes et al., 2011; Narytnyk et al., 2014a,b). Briefly,
cultures were fixed (4% paraformaldehyde), rinsed, blocked, and
incubated overnight with primary antibodies in 0.1% Triton X-100 in the
cold. Subsequently, cultures were rinsed, incubated with secondary
antibodies, rinsed and mounted with Vectashield hard set mounting
medium with DAPI. Fluorescence was observed with an Axio Imager Z1
fluorescence microscope or with a Nikon Eclipse Ti confocal microscope.
Secondary antibodies were designed for multiple labelling with minimal
cross-reactivity with human, bovine, horse, rabbit/mouse and swine serum
proteins. Negative controls did not show immunofluorescence. Data were
statistically analysed using Dunnett's test. Primary and secondary antibodies
are detailed in supplementary material Table S1.
Electron microscopy
Co-cultures of hEPI-NCSC-derived Schwann cells with rat DRG explants
were fixed for electron microscopy with 2.5% glutaraldehyde in 0.1 M
Sorenson’s phosphate buffer for 1 h at room temperature, rinsed with
Sorenson’s phosphate buffer, the DRG in the centre of the co-culture removed
leaving axons and Schwann cells attached to the culture well, well bottoms
isolated, shipped in buffer at room temperature and processed for electron
microscopy as follows: post-fixation in 1% osmium tetroxide in PBS,
dehydration in a graded series of ethanol, embedding in Epon resin and
polymerisation for 48 h at 60°C. The region of interest was identified using a
light microscope, cut out with a single-edge razor blade, flat-embedded in
Epon resin and polymerised as before. Ultrathin sections of 70 nm were cut
with aDiatome diamond knife, mounted on pioloform/carbon films on copper
slot grids and counterstainedwith4%uranyl acetate andReynolds’ lead citrate.
Images were taken using a JEM 1400 transmission electron microscope
equipped with an AMT XR60 digital camera.
RNA isolation, gene expression profiling and quantitative real-
time PCR (qPCR)
Total RNA was extracted from snap-frozen homogenised cells at D−3 and
D21, and RNA purity was determined using an Agilent 2100 Bioanalyser
[RNA integrity number (RIN) values: D−3, 9.9; D21, 10.0]. Gene expression
profiling was performed by the Genome Centre at Barts and The London
School of Medicine and Dentistry using a Human HT-12 v4 array and the
Illumina platform. Data have been deposited in the NCBI Gene Expression
Omnibus with accession number GSE61273. For qPCR, 1 µg total RNAwas
incubatedwithDNaseI and processed exactly as described previously (Clewes
et al., 2011). Ct values for targets were normalised to the average Ct value of
GAPDH. Fold changes in expression were calculated using the ΔΔCt method.
Primers are listed in supplementary material Table S1.
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